Publications by authors named "Michael W Rowe"

Claim this Profile
C
Clinically significant novel biomarkers for prediction of first ever myocardial infarction: the Tromsø Study.
Tom Wilsgaard, Ellisiv Bøgeberg Mathiesen, Anil Patwardhan, Michael W Rowe, Henrik Schirmer

Circ Cardiovasc Genet· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of a multi-marker diabetes risk score in the Insulin Resistance Atherosclerosis Study (IRAS), a multi-ethnic US cohort.
Michael W Rowe, Richard N Bergman, Lynne E Wagenknecht, Janice A Kolberg

Diabetes Metab Res Rev· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a multi-marker model for the prediction of incident type 2 diabetes mellitus: combined results of the Inter99 and Botnia studies.
Valeria Lyssenko, Torben Jørgensen, Robert W Gerwien, Torben Hansen, Michael W Rowe

Diab Vasc Dis Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort.
Janice A Kolberg, Torben Jørgensen, Robert W Gerwien, Sarah Hamren, Michael P McKenna, Michael W Rowe

Diabetes Care· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a screening assay for surrogate markers of CHK1 inhibitor-induced cell cycle release.
Christie P Fanton, Michael W Rowe, Edward J Moler, Marjorie Ison-Dugenny, Susan K De Long

J Biomol Screen· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis